VIM and breast cancer: SMRwt breast cancer derived exosomes had Vimentin and Mortalin protein expression levels reduced to 46.56% and 45.64% for MDA-MB-231 and 61.56% and 35.99% for MCF-7 (Fig. 6C,D).